Federation Des Caisses Desjardins Du Quebec Agenus Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.53 - $0.93 $1,060 - $1,860
2,000 New
2,000 $1.16 Million
Q2 2022

Aug 14, 2024
SELL
$1.3 - $2.64 $1,300 - $2,640
-1,000 Closed
0 $0
Q1 2022

Aug 14, 2024
BUY
$2.35 - $3.47 $2,350 - $3,470
1,000 New
1,000 $2.46 Million
Q3 2018

Aug 30, 2024
SELL
$1.59 - $2.42 $19,239 - $29,282
-12,100 Closed
0 $0
Q3 2017

Aug 30, 2024
BUY
$3.48 - $4.44 $27,840 - $35,520
8,000 Added 195.12%
12,100 $53.4 Million
Q2 2017

Aug 30, 2024
BUY
N/A
4,100
4,100 $16 Million

Others Institutions Holding AGEN

# of Institutions
8
Shares Held
2.07M
Call Options Held
0
Put Options Held
0
View Full List

About AGENUS INC

AGEN Quotes by TradingView
  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email